Publication | Closed Access

Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses

VaccinationMucosal VaccinationCross-protectionVaccine DevelopmentNew TypeMedicineImmunologyHumoral ImmunityInfluenza VaccineCellular Immune ResponsesVaccine DesignInfluenza Subunit VaccineEgg-based Vaccine ProductionInfluenza Vaccines